Compositions for the Prevention and / or treatment of Macular Degeneration and / or loss of Visual Acuity

摘要

This relates to a Composition of dietary or Nutritional supplement that strengthens and promotes the health of the retina.Claim 1: a composition comprising: a daily dose of about 400 to 600 milligrams of vitamin C, approximately 350 to 450 IU of vitamin E, about 1 to 20 mg of Lutein; approximately 20 to 42 mg of zinc; approximately 1000 to 1800 Milligrams of omega-3 Fatty Acids, and approximately 0.8 to 1.35 mg of Copper.Claim 2: the composition according to claim 1 which comprises zeaxanthin, preferably in an amount of about 1.7 to 2.3 milligrams. Claim 3: the composition according to claim 1, wherein the Omega 3 fatty acids include Docosahexaenoic acid and eicosapentaenoic acid.Claim 1: the composition according to claim 8, wherein the coating is a zwitterionic phospholipid that includes but is not limited to phosphatidyl choline, phosphatidyl Serine, phosphatidyl Ethanolamine, -, sphingomyelin and Ceramide, as well as several other phospholipids Zwitte Rionicos.Claim 1: a composition according to claim 1, which is a tablet, capsule or agglomerated, and includes: 500 milligrams of vitamin C (ascorbate Dihydrate calcium, USP) 400 IU of vitamin E (Alpha Tocopheryl Acetate, USP), 40 milligrams of Zinc Gluconate, 4.7 my Ligramos? 1.5 milligrams of Copper sulphate or Copper Oxide, 2,14 milligrams of Copper carbonate, 8.58 milligrams of Copper gluconate, 400 milligrams of 600 milligrams of DHA, EPA, 1200 milligrams of total Omega 3 fatty acids (omega-3 Fatty Acid triglycerides, European Pharmacopoeia 10 mg), Lutein (natural Source floraglo 20 C Slow (which includes some zeaxanthin) or pure), 2 milligrams of zeaxanthin (Synthetic Origin),Optionally comprising the following Ingredients to make a Cover: 175 Young bovine Gelatine, Glycerine USP Flakes 99 percent of soybean oil (soybean oil, Hydrogenated) NF, USP, USP and Titanium dioxide.Claim 1: the use of a composition according to any of the preceding Claims, in the preparation of a Medicament for the Prevention and / or treatment of age related Macular Degeneration (AMD) and / or Diabetic Retinopathy (DR).